Avid Bioservices Inc (CDMO)

[eb0783]

Yes, since Avid alone is probably worth $2 to $3 per share today, I see it as the savior of us IF any trials EVER fail. Of course we know that NONE have failed to date. (some {NSCLC Phase II} have been absolutely astonishing once the REAL results are considered) ALL have proceeded in concert with, or better than, the pre-clinical trials for the same indications. This is the greatest reward to risk investment that I have ever seen. imo